• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
Read more
© NCI/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 14th February 2011

New OHE Commission on Competition in the NHS

Competition in the NHS is viewed as if it must either be for everything the NHS provides to patients or for nothing. Neither extreme is likely to produce the most socially beneficial outcome. To examine the appropriate role of competition…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email
Commission214_30Jan

Competition in the NHS is viewed as if it must either be for everything the NHS provides to patients or for nothing. Neither extreme is likely to produce the most socially beneficial outcome. To examine the appropriate role of competition in the NHS, the OHE has established an expert Commission on Competition, expected to produce a report by year’s end.

Commission214_30Jan

The debate about the role of competition in the NHS is polarised. Competition is treated as if it must either be for everything the NHS provides to patients or for nothing. But such extreme positions are unlikely to represent the most socially beneficial outcome. The OHE therefore has established an expert Commission on Competition in the NHS.

The purpose of the Commission is to investigate for which health care services and in which circumstances competition or contest is likely to be beneficial overall and for which it is likely to be harmful.

The Commission will collect evidence, consider and make recommendations to policy makers and implementers in the UK on the following.

  • The characteristics of publicly funded health care services that determine whether competition or contest is likely to be beneficial
  • Non-price and price competition
  • How competition and contest, where potentially beneficial, might be enabled, promoted and regulated

The Chair of the Commission is James Malcomson, Professor of Economics at the University of Oxford and Fellow of All Souls College. The members collectively provide expertise and experience in key areas: competition and/or regulation economics, NHS economics, health policy, NHS management and health care provision.

Commission members

James Malcomson (Chair), Professor of Economics, University of Oxford and Fellow of All Souls College

Mike Bailey, Medical Director and Deputy Chief Executive, St George's Healthcare NHS Trust

Anita Charlesworth, Chief Economist, The Nuffield Trust

Nigel Edwards, Acting Chief Executive, NHS Confederation

Julian Le Grand, Richard Titmuss Professor of Social Policy, London School of Economics

Carol Propper, Professor of Economics, Imperial College and Bristol University

Bob Ricketts, Director, Provider Policy, Department of Health

Jon Sussex, Deputy Director, Office of Health Economics

Adrian Towse, Director, Office of Health Economics

The Commission expects to complete its work during 2011 and will publish its report before the end of the year, summarising the evidence and making recommendations for policy and implementation.

The Commission would be pleased to receive evidence of direct relevance to its considerations. Those who wish to contribute evidence should initially send a short note (maximum one page), setting out the nature of the evidence they wish to submit, to the Secretariat of the OHE Commissionat OHE.  The Commission will invite more detailed submissions where it believes these will help its deliberations.

  • Healthcare Systems
  • Commission

Related News

  • News
  • May 2019

OHE Lunchtime Seminar: Incentives for R&D, Competition and Intertemporal Effects of Payment Rules for Cures

Read more
  • News
  • November 2018

OHE Lunchtime Seminar: Price Regulation of Generics and Drug Shortages

Read more
  • News
  • November 2018

OHE Lunchtime Seminar: Price Regulation of Generics and Drug Shortages

Read more
  • News
  • September 2018

Private Provision of Publicly Funded Health Care: The Economics of Ownership

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!